1. Home
  2. WSR vs REPL Comparison

WSR vs REPL Comparison

Compare WSR & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Whitestone REIT

WSR

Whitestone REIT

HOLD

Current Price

$15.96

Market Cap

775.0M

Sector

Real Estate

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$8.02

Market Cap

692.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSR
REPL
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
775.0M
692.8M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
WSR
REPL
Price
$15.96
$8.02
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$16.50
$11.13
AVG Volume (30 Days)
181.7K
1.1M
Earning Date
06-01-2026
05-04-2026
Dividend Yield
3.79%
N/A
EPS Growth
N/A
5.25
EPS
0.52
N/A
Revenue
$154,282,000.00
N/A
Revenue This Year
$0.31
N/A
Revenue Next Year
$4.07
N/A
P/E Ratio
$28.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.43
$2.68
52 Week High
$15.50
$13.24

Technical Indicators

Market Signals
Indicator
WSR
REPL
Relative Strength Index (RSI) 69.07 52.76
Support Level $11.86 $6.90
Resistance Level N/A $8.07
Average True Range (ATR) 0.34 0.59
MACD 0.01 -0.04
Stochastic Oscillator 94.93 58.13

Price Performance

Historical Comparison
WSR
REPL

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: